Utah vaccine exemption rate rises to No. 2 in nation
Threat level: Utah's kindergarten vaccination rates have long fallen below the 95% needed for herd immunity against highly contagious illnesses — and kids are about to return to school amid a measles outbreak.
As of fall 2024, just 88.6% of Utah kindergartners were up to date on their measles-mumps-rubella (MMR) vaccines, per new CDC data. Whooping cough was at 88.1%.
Meanwhile, whooping cough is spreading in southwest Utah, health officials announced last week.
What we're watching: Kindergarten vaccination rates in parts of Utah are dropping toward the 80% herd immunity threshold for polio, per the latest data from the state health department.
More than 19% of kindergartners in southwest Utah were not fully vaccinated for polio, with nearly 15% in the central counties.
The big picture: Anti-vax sentiments — once considered a liberal trend — gained ground on the political right amid hostility toward COVID prevention measures.
A Gallup poll last year found that 69% of respondents viewed childhood vaccines as "extremely" or "very" important, down from 94% in 2001 — a drop researchers attributed to those who lean Republican.
By the numbers: More than 10% of Utah kindergartners obtained immunization waivers last fall, up a full percent from the previous year.
Only Idaho had a higher rate of exemptions, at 15.4%.
The intrigue: Of the 10.3% of Utah kindergartners who sought exemptions, just 0.3% were for medical reasons.
About 85% were for "personal" reasons, with "religion" accounting for another 12.5%.
Catch up quick: A 2022 Axios analysis of Utah immunization data by ZIP code showed exemptions after 2020 largely spiked in politically conservative areas.
Caveat: Vaccine waivers are far more common among online students, covering more than half of the state's nearly 1,500 online kindergartners.
Of the 44,000 in-person kindergartners, 9% had exemptions, up from 7.9% a year before. Another 1% were out of compliance — neither vaccinated nor exempt.
Flashback: Trump cut more than $30 million in Utah childhood immunization funding in April.
Zoom in: Salt Lake County's exemption rate was the lowest of any local health district in the state at 5.5%.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
15 minutes ago
- New York Post
‘Flesh-eating bacteria' cases rising across the Gulf Coast, killing 1 in 5 who contract the nasty infection
Officials are cautioning against swimming in waters along the Gulf Coast as 'flesh-eating bacteria' cases spike in the South, leaving eight people dead so far across Florida and Louisiana. So far this year, Louisiana health officials have confirmed a staggering 17 cases of Vibrio vulnificus, a nasty bacterial infection that can cause blood poisoning, and four deaths. The number marks a concerning uptick from the average seven annual cases the Bayou State has seen over the past decade, according to the Louisiana Department of Health. 4 Beachgoers in Florida and Louisiana should be on guard for 'flesh-eating bacteria,' health officials warned. trongnguyen – All 17 people were hospitalized, including the four who died. Florida, despite being the more prominent vacation hotspot, is faring slightly better with 13 confirmed cases and four deaths. Last year, 15 cases were reported in Pinellas County alone, just outside of Tampa, and 19 people died of the gnarly bacteria statewide, according to the Florida Department of Health. 4 Vibrio vulnificus can cause blood poisoning in fatal cases. Love Employee – The bacteria can enter people's systems either through open wounds exposed to tainted waters or by eating infected seafood, particularly oysters, where it tends to 'concentrate,' according to the Centers for Disease Control and Prevention. The flesh-eating germs thrive in warm, brackish waters between May and October, making the Gulf Coast the perfect breeding ground. 4 The bacteria tend to 'concentrate' in shellfish, mainly oysters. vichie81 – From there, it can cause a wound or bloodstream infection that, if left untreated, can become fatal in mere days and even require the amputation of entire limbs to 'remove dead or infected tissue,' according to the CDC. The bloodstream infection — the more fatal of the two — can cause blistering skin lesions, which give the appearance that something is gnawing away at a person from the inside out, giving the bacteria its infamous 'flesh-eating' notoriety. 4 Vibrio vulnificus in the blood can cause blistering skin lesions. NEJM Other signs and symptoms can include fever, redness, pain, swelling, warmth, discoloration and discharge, according to the CDC. Some people are at higher risk of death if they are infected with the bacteria, including those with preexisting health issues like cancer, diabetes, or liver disease, according to the Louisiana Department of Health. If caught early enough, many cases can be treated with antibiotics, according to the CDC. Roughly 80,000 cases of vibriosis occur each year in the US, according to the health agency. A majority of the recorded cases were linked to contaminated food.
CBS News
16 minutes ago
- CBS News
Florida officials warn about risks of drinking raw milk after 21 people sickened
The Florida Department of Health is warning about the risks of drinking raw, unpasteurized milk after 21 people, including six children under the age of 10, were sickened by E. coli and campylobacter bacteria linked to raw milk from the same farm. Seven people have been hospitalized, and two have developed severe complications. "Sanitation practices in this farm are of particular concern due to the number of cases," the department said in a news release. Officials did not identify the farm, but indicated its products were available in Northeast and Central Florida. Although it is illegal to sell raw milk for human consumption in Florida, it can be sold in the state if it's labeled as a pet food. Raw milk has been promoted by online wellness influencers and raw food advocates, boosting sales in recent years, but public health officials say it can be risky. The Food and Drug Administration and the Centers for Disease Control and Prevention say raw milk can carry life-threatening bacteria, such as E. coli, campylobacter, listeria or salmonella. These can cause symptoms including diarrhea, vomiting and stomach cramps. Severe cases can result in a condition called hemolytic uremic syndrome, or HUS, which can lead to kidney failure. Since 1987, 143 outbreaks have been linked to raw milk or raw milk products, some involving miscarriages, stillbirths, kidney failure and even deaths, according to the FDA. Pasteurization — a process of heating the milk — kills these bacteria. Pasteurization is required by federal law for any milk sold across state lines. Some individual states also restrict or ban the sale of raw milk, but others allow it. In an interview with CBS News Miami earlier this year, Mark McAfee, founder of one of the world's largest raw milk producers and head of an advocacy group called the Raw Milk Institute, claimed raw milk offers health benefits such as bioactives that boost the immune system. McAfee sells his raw milk legally in California, where no state law prohibits its sale. But the CDC says such claims are unfounded. "Pasteurized milk offers the same nutritional benefits without the risks of raw milk consumption," the agency says. The Florida Department of Health noted in its statement that "many people consume raw milk safely." But it also advised, "Floridians should be aware of potential risks associated with consumption, which may vary depending on the source of producer's handling of raw milk and milking procedures are vital in prevention of contamination."
Miami Herald
an hour ago
- Miami Herald
enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to Discuss How President Trump's Recent CVI Diagnosis May Impact the Company
- enVVeno is developing the VenoValve as a potential treatment option for the approximately 2.5 million patients in the U.S. suffering from severe deep Chronic Venous Insufficiency - FDA decision expected in 2H'2025 - Access the "What This Means" segment here IRVINE, CA / ACCESS Newswire / August 4, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno Medical" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that it participated in a Virtual Investor "What This Means" segment entitled, "enVVeno Medical - Making Veins Work Again - How President Trump's CVI Diagnosis is Raising Awareness." Rob Berman, CEO and Dr. Marc Glickman, CMO of enVVeno Medical discussed the progressive nature of chronic veinous insufficiency and whether President Trump may one day be a candidate for the VenoValve® following U.S. Food and Drug Administration (FDA) approval. The Company estimates that there are approximately 2.5 million patients in the U.S. that could be candidates for the VenoValve. The Company has submitted a pre-market authorization (PMA) application for the VenoValve to the FDA, with a decision anticipated in the second half of 2025. The "What This Means" segment can be accessed here. About CVI Severe deep venous CVI is a serious and debilitating disease that is most often caused by blood clots (deep vein thromboses or DVTs) in the deep veins of the leg. When valves inside of the veins of the leg fail, blood flows in the wrong direction and pools in the lower leg, causing pressure within the veins of the leg to increase (venous hypertension). Symptoms of CVI include leg swelling, pain, edema, and in the most severe cases, recurrent open sores known as venous ulcers. The disease can severely impact everyday functions such as sleeping, bathing, dressing, and walking, and is known to result in high rates of depression and anxiety. There are currently no effective treatments that repair deep venous valve dysfunction, the #1 cause of severe CVI-a disease estimated to cost the U.S. healthcare system in excess of $26 billion each year. About enVVeno Medical Corporation enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company's lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the VenoValve U.S. pivotal study and the Company is currently performing the final testing necessary to seek approval for the pivotal trial for enVVe. INVESTOR CONTACT: Jenene Thomas, JTC Team, LLCNVNO@ 824-0775 MEDIA CONTACT:Glenn Silver, FINN 818-8198 SOURCE: enVVeno Medical Corporation
